It is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.Form:Light Yellow Solid Melting Point:203-205°CSolubility:DMSO, Methanol (Sparingly)